Log in to save to my catalogue

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lun...

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lun...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8510914

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer

About this item

Full title

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer

Publisher

New York: Springer US

Journal title

Lung, 2021-10, Vol.199 (5), p.549-557

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Purpose
To investigate whether eosinophils and other white blood cell subtypes could be used as response and prognostic markers to anti-Programmed cell Death-1 or anti-PD-Ligand-1 treatments in non-small cell lung cancer patients.
Methods
We retrospectively analyzed data from the NSCLC patients consecutively treated at our hospital with a...

Alternative Titles

Full title

White Blood Cells in Patients Treated with Programmed Cell Death-1 Inhibitors for Non-small Cell Lung Cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8510914

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8510914

Other Identifiers

ISSN

0341-2040,1432-1750

E-ISSN

1432-1750

DOI

10.1007/s00408-021-00474-2

How to access this item